phenylalanyl-prolyl-arginine-chloromethyl ketone and Autosomal Hemophilia A

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Autosomal Hemophilia A in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carr, ME; Carr, SL; Martin, EJ	1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Autosomal Hemophilia A

Article	Year
Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:3 Topics: Adult; Amino Acid Chloromethyl Ketones; Batroxobin; Blood Coagulation; Blood Platelets; Calcium; Clot Retraction; Dose-Response Relationship, Drug; Elasticity; Female; Hemophilia A; Humans; Male; Platelet Activation; Thrombin	2002

Article

Year

Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:3

Topics: Adult; Amino Acid Chloromethyl Ketones; Batroxobin; Blood Coagulation; Blood Platelets; Calcium; Clot Retraction; Dose-Response Relationship, Drug; Elasticity; Female; Hemophilia A; Humans; Male; Platelet Activation; Thrombin

2002